SteriPack is a leading global contract manufacturer serving the medical device, pharmaceutical and diagnostic markets. Inflexion led the buyout of SteriPack in 2022, with the investment being made from Buyout Fund VI.
SteriPack is a leading global contract manufacturer serving the medical device, pharmaceutical and diagnostic markets. SteriPack provides outsourced design, development, manufacturing, assembly, packaging, sterilization and supply chain, producing a range of products. The company employs over 650 people from its locations in Ireland, Poland, Malaysia, and the US, and has over 100 global clients.
The Inflexion difference
The funding from Inflexion will support the business to continue to scale globally as it benefits from strong market growth and further international expansion opportunities. SteriPack is also well placed to undertake further acquisitions globally.